Sort
40,608 grants matching “prostate cancer”
Developmental Funds
$441,094Eric P Winer · Yale University · P30 · FY2024 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$441,068Washington University · N01 · FY2008 · CA
Metabolic Mechanisms for Programmed Cell Death
$441,041James M Phang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function from Various Organisms for the Development of Antibiological Agents
$440,999Juliane K Strauss-Soukup · Creighton University · R15 · FY2023 · GM
TISSUE PROTEIN PROFILING/IMAGING SHARED RESOURCES
$440,965Richard M Caprioli · Vanderbilt University · P30 · FY2007 · CA
Cell Survival Advantage in Cadmium Induced Carcinogenesis
$440,953Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2021 · ES
Leadership, Administrative, and Food Composition Core
$440,913Walter C. Willett · Harvard School Of Public Health · P01 · FY2007 · CA
Uncovering the Mechanisms of Metastasis in Fallopian Tube-Originated Ovarian Cancer
$440,775Yang Yang-Hartwich · Yale University · R01 · FY2022 · CA
Computational Studies of Ion-Induced Water Radiolysis and DNA Damage
$440,768Jorge Alberto Morales · Texas Tech University · R15 · FY2019 · GM
RET Regulation and Targeting in Neuroendocrine Prostate Cancer
$440,732Justin Michael Drake · University Of Minnesota · R01 · FY2025 · CA
RET Regulation and Targeting in Neuroendocrine Prostate Cancer
$440,732Justin Michael Drake · University Of Minnesota · R01 · FY2022 · CA
Combinatorial Nanotherapeutic Approach for Advanced Prostate Cancer Treatment
$440,708Oleh Taratula · Oregon State University · R15 · FY2016 · EB
Effect of DNA repeat silencing on efficacy of ATRi in prostate cancer treatment
$440,628Eric J Brown · University Of Pennsylvania · R01 · FY2024 · CA
Genetic Epidemiology of Prostate Cancer Risk and Progression
$440,611John S Witte · University Of California, San Francisco · R01 · FY2015 · CA
Energetic Factors, Lethal Prostate Cancer, and Survivorship
$440,594Jing Ma · Harvard School Of Public Health · U54 · FY2014 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
ST Louis-Cape Girardeau CCOP
$440,482Bethany Sleckman · St. John'S Mercy Medical Center · U10 · FY2007 · CA
Developing knowledge models to enable rapid learning in radiation therapy
$440,476Qingrong Jackie Wu · Duke University · R01 · FY2017 · CA
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias
$440,450Aasthaa Bansal · University Of Washington · R37 · FY2023 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$440,421Susan Halabi · Duke University · U01 · FY2014 · CA
A developmental engineering toolbox for controlled epithelial morphogenesis
$440,375Alex Hughes · University Of Pennsylvania · R35 · FY2025 · GM
Multiscale hydrogel biomaterials-enabled 3D modeling of cancer drug resistance
$440,347Xiaoming He · Univ Of Maryland, College Park · R01 · FY2023 · CA
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
$440,344Celine Dermardirossian · Scripps Research Institute, The · R01 · FY2017 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$440,336University Of Arizona · U10 · FY2002 · CA
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$440,314Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2023 · CA